Tepperman B L, Brown J F, Whittle B J
Department of Pharmacology, Wellcome Research Laboratories, Beckenham, Kent, United Kingdom.
Am J Physiol. 1993 Aug;265(2 Pt 1):G214-8. doi: 10.1152/ajpgi.1993.265.2.G214.
The present study determined the presence of constitutive and inducible nitric oxide (NO) synthase activities in intestinal isolated epithelial cells and the effects of NO induction on intestinal epithelial cell viability. Epithelial cells were isolated from rat proximal small intestine by dispersion using citrate and EDTA. Constitutive NO synthase activity, determined by [14C]arginine conversion to citrulline that was inhibited by in vitro incubation with the arginine analogue NG-monomethyl-L-arginine (L-NMMA; 300 microM) or ethylene glycol-bis (beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA; 1 mM), was observed in these cells. Administration of Escherichia coli lipopolysaccharide (LPS; 3 mg/kg iv) significantly augmented NO synthase activity (determined 4 h later), which was inhibited in vitro by incubation with L-NMMA but not by EGTA. The highest level of constitutive and inducible NO synthase activity occurred in intestinal villus cells, and the lowest was in crypt cells. Induction of NO synthase activity was associated with a decrease in cellular viability as assessed by a decrease in trypan blue exclusion. Dexamethasone pretreatment (1 mg/kg iv 2 h before LPS administration) significantly reduced both induction of NO synthase activity and the reduction in cellular viability. Likewise concurrent administration of the NO synthase inhibitor NG-nitro-L-arginine methyl ester (10 mg/kg sc) ameliorated the reduction in cell viability induced by LPS administration, an effect abolished by pretreatment with the NO substrate L-arginine (350 mg/kg sc). Whereas constitutively formed NO may have a physiological role in these cells, the results in this study suggest that induction of NO synthase in epithelial cells may represent a mechanism of local intestinal damage.
本研究确定了肠道分离上皮细胞中组成型和诱导型一氧化氮(NO)合酶活性的存在,以及NO诱导对肠道上皮细胞活力的影响。使用柠檬酸盐和乙二胺四乙酸(EDTA)通过分散法从大鼠近端小肠分离上皮细胞。通过[14C]精氨酸转化为瓜氨酸来测定组成型NO合酶活性,体外与精氨酸类似物NG-单甲基-L-精氨酸(L-NMMA;300μM)或乙二醇双(β-氨基乙基醚)-N,N,N',N'-四乙酸(EGTA;1 mM)孵育可抑制该活性,在这些细胞中观察到了这种活性。静脉注射大肠杆菌脂多糖(LPS;3 mg/kg)显著增强了NO合酶活性(4小时后测定),体外与L-NMMA孵育可抑制该活性,但与EGTA孵育则不能。组成型和诱导型NO合酶活性的最高水平出现在肠绒毛细胞中,最低水平出现在隐窝细胞中。通过台盼蓝排斥率降低评估,NO合酶活性的诱导与细胞活力下降相关。地塞米松预处理(LPS给药前2小时静脉注射1 mg/kg)显著降低了NO合酶活性的诱导以及细胞活力的降低。同样,同时给予NO合酶抑制剂NG-硝基-L-精氨酸甲酯(10 mg/kg皮下注射)可改善LPS给药诱导的细胞活力降低,L-精氨酸(350 mg/kg皮下注射)预处理可消除该作用,而L-精氨酸是NO的底物。虽然组成型形成的NO可能在这些细胞中具有生理作用,但本研究结果表明上皮细胞中NO合酶的诱导可能代表了局部肠道损伤的一种机制。